Association between clinicopathological features and prognosis significance of PD-L1 expression in small cell lung cancer patients: a systemic review and meta-analysis

BACKGROUND: Programmed death ligand-1 (PD-L1) has been identified as an established biomarker for predicting response to immunotherapy in a variety types of cancer. However, the clinicopathological and prognostic significance of this protein in small cell lung cancer (SCLC) patients remains controve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zongtao, Lu, Lin, Fei, Zhenle, Lv, Donglai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798485/
https://www.ncbi.nlm.nih.gov/pubmed/35117915
http://dx.doi.org/10.21037/tcr-20-1512a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798485/
https://www.ncbi.nlm.nih.gov/pubmed/35117915
http://dx.doi.org/10.21037/tcr-20-1512a

Ejemplares similares